Navigation Links
Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
Date:8/7/2008

co-lead the firm's Business Development Practice and spearheaded the development of the firm's operations in the United Kingdom and Europe.

In his new role as Chief Operating Officer, Mr. Naeymi-Rad will oversee all business operations of the six consulting practice areas at Campbell Alliance and work to refine core business processes and improve operational alignment among the practice areas. These efforts will include enhancing methods and tools, identifying and shaping new service offerings and new potential practice areas, and leading the firm's next generation approach to account management.

"I'm proud to say that our business has demonstrated a consistently aggressive growth pace while maintaining stellar client satisfaction. I'm looking forward to the challenge of taking on this new role and helping the firm to further differentiate its offerings and continue its expansion into both new practice areas and geographic areas," stated Mr. Naeymi-Rad.

Mr. Naeymi-Rad has been published in numerous industry journals and is a frequent speaker at industry conferences, having served in a chairperson role on many occasions, covering topics related to developing and implementing commercial strategies and improving commercial processes.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For mor
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
5. David Mott Appointed Non Executive Director at Shire
6. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
7. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
8. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
9. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
10. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
11. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 India’s ... business can potentially be worth up to a ... opportunity, the Indian government is taking serious action ... the process. , This presentation will examine:, ... regulations ,     Immediate and long term impacts ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to publish ... sulfur in ultra-low sulfur diesel (ULSD) using the new ... . The analysis detailed in Rigaku Application Note 1272 ... International Standard specifies an energy dispersive X-ray fluorescence (EDXRF) ... automotive gasoline. , Regulations around the world have limited ...
(Date:6/19/2013)... A new look at “big glass” and visionary ... highlight technical sessions at SPIE Photomask Technology 2013 ... year, the three-day event is the industry’s largest mask ... 100 technical presentations and numerous networking lunches and receptions. ... and photonics , the meeting will be held at ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... Acquisition Extends Elsevier,s Ability to Gather Global Healthcare News and, ... Increase ... Business Value for Customers, PHILADELPHIA, March 10 ... information, announced,today that it has acquired Windhover Information Inc., a ...
... March 10 Caliper Life,Sciences, Inc. (Nasdaq: ... the,Cowen and Company 28th Annual Health Care Conference ... at 2:30 p.m. EDT. Kevin Hrusovsky, President,and CEO ... the company,s business.,The live webcast can be accessed ...
... used by Avexa to select patients and optimize ... background therapy in phase III program, SOUTH SAN FRANCISCO, ... today that the Company,has signed an agreement with AVEXA Limited (ASX: ... technology in support of,Avexa,s drug discovery and development programs., Avexa ...
Cached Biology Technology:Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 2Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 3Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 2Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 3Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 4Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts 5
(Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...
(Date:6/18/2013)... a hacker lab. At Brandeis University, sophisticated computational ... helping scientists understand the complex interplay between genomic ... virus, outer "shell" critical for replication. ... we are finding will help researchers alter virus ... fellow Jason Perlmutter, first author of the scientific ...
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... Oct. 17, 2011 Dr. Randal Halfmann, a research ... 10 investigators selected for the first National Institutes of ... program allows creative early-career scientists to leapfrog the traditional ... investigations. The charter group of awardees will share approximately ...
... It is becoming more and more common to install ... but not all roofs are equally suitable. Scientists from the ... the actual conditions to determine the maximum possible magnitude of ... a particular roof. The scientists have surveyed Gothenburg in a ...
... 17 October 2011 - Genomatix is among the 41 ... European Commission as a high impact project within its ... generation sequencing data analysis and the development of an ... to researchers within and outside the consortium. "To ...
Cached Biology News:UT Southwestern biochemist receives new NIH Early Independence Award 2Now you can determine the solar efficiency of your roof 2
Rad51, N-terminal...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Biology Products: